| 1 |
Anticancer activity for 4,4′-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007) analogues and Their abilities to interact with lymphoendothelial cell surface markers
Lee Roy Morgan, Branko S. Jursic, Catherine L. Hooper et al. · Bioorganic & Medicinal Chemistry Letters
|
Dec 2002 |
185 |
| 2 |
Methods of cooling: Practical aspects of therapeutic temperature management
David B. Seder, Thomas E. Van der Kloot · Critical Care Medicine
|
15 Jun 2009 |
93 |
| 3 |
Design, Synthesis, and Anticancer Properties of 4,4‘-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone and Analogues
Lee Roy Morgan, Kanappan Thangaraj, Blaise W. LeBlanc et al. · Journal of Medicinal Chemistry
|
6 Sep 2003 |
58 |
| 4 |
Carbonate and carbamate derivatives of 4-demethylpenclomedine as novel anticancer agents
Lee Roy Morgan, Robert F. Struck, William R. Waud et al. · Cancer Chemotherapy and Pharmacology
Open access |
2 Mar 2009 |
22 |
| 5 |
Preparation of silver/PMMA beads via the in sito reduction of a silver alkylcarbamate complex
Young Min Jeon, Myoung Seon Gong, Hyun Nam Cho · Macromolecular Research
|
2009 |
20 |
| 6 |
Comparative preclinical toxicology and pharmacology of isophosphoramide mustard, the active metabolite of ifosfamide
Nathalie Germann, Saı̈k Urien, Andrew H. Rodgers et al. · Cancer Chemotherapy and Pharmacology
|
14 Sep 2004 |
12 |
| 7 |
Treatment of recurrent metastatic uterine leiomyosarcoma of the spine: a multimodality approach using resection, radiosurgery, and chemotherapy
Michael J. Strong, Trevor Rosenlof, Siddhartha Padmanabha et al. · Journal of Neurosurgery Spine
Open access |
17 Jul 2015 |
11 |
| 8 |
Anticancer Properties for 4,4′-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007)/3,7-Diaminophenothiazin-5-ium Double Salts
Lee Roy Morgan, Andrew H. Rodgers, Blaise W. LeBlanc et al. · Bioorganic & Medicinal Chemistry Letters
|
Aug 2001 |
11 |
| 9 |
N-Alkylation of Aromatic and Heteroaromatic-2,4-dinitrophenylhydrazones with Potassium Fluoride on Alumina
Kannappan Thangaraj, Lee Roy Morgan · Synthetic Communications
|
Jul 1994 |
10 |
| 10 |
4,4′-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007): a topical treatment for cutaneous metastases from malignant cancers
David S. Eilender, Patricia Mucci LoRusso, Leonard C. Thomas et al. · Cancer Chemotherapy and Pharmacology
|
23 Sep 2005 |
9 |
| 11 |
BACPTDP: a water-soluble camptothecin pro-drug with enhanced activity in hypoxic/acidic tumors
David J. Adams, William R. Waud, Mansukh C. Wani et al. · Cancer Chemotherapy and Pharmacology
Open access |
21 Jun 2010 |
7 |
| 12 |
Comparative preclinical toxicology and pharmacology of 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007) in vitro and in rodents and primates.
Lee Roy Morgan, Andrew H. Rodgers, D. Fan et al. · PubMed
|
28 May 1997 |
5 |
| 13 |
Acyl derivatives of demethylpenclomedine, an antitumor-active, non-neurotoxic metabolite of penclomedine
Robert F. Struck, Anita Tiwari, Henry S. Friedman et al. · Cancer Chemotherapy and Pharmacology
|
Jul 2001 |
5 |
| 14 |
High-performance liquid chromatographic determination of 4,4′-dihydroxybenzophenone-2,4-dinitrophenylhydrazone in plasma
Andrew H. Rodgers, Sandhya Subramanian, Lee Roy Morgan · Journal of Chromatography B Biomedical Sciences and Applications
|
Aug 1995 |
3 |
| 15 |
Early Phase I Results for 4-Demethyl-4-cholesteryloxypenclo-medine [DM-CHOC-PEN] as Therapy in Adolescent and Young Adult (AYA) Subjects with Advanced Malignancies
Lee Roy Morgan, Roy S. Weiner, Marcus L. Ware et al. · Journal of cancer research updates
|
23 Jun 2018 |
2 |
| 16 |
Comparative dermal pharmacology and toxicology of 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007) in rodents and primates.
LR Morgan, Rodgers Ah, Hooper Cl et al. · PubMed
|
24 Sep 2002 |
2 |
| 17 |
ATCT-33RESULTS FROM EARLY CLINICAL TRIALS FOR 4-DEMETHYL-4-CHOLESTERYLOXYCARBONYLPENCLOMEDINE (DM-CHOC-PEN)
Marcus L. Ware, Roy S. Weiner, Paul Friedlander et al. · Neuro-Oncology
Open access |
Nov 2015 |
2 |
| 18 |
ATPS-23MULTIMODALITY TREATMENT FOR METASTATIC, RECURRENT PINEAL PARENCHYMAL TUMOR OF INTERMEDIATE DIFFERENTIATION: A NOVEL TREATMENT APPROACH
Juanita Garces, Franklin Berry, Mansour Mathkour et al. · Neuro-Oncology
Open access |
Nov 2015 |
1 |
| 19 |
Gas chromatography–electron ionization mass spectrometry and liquid chromatography–electrospray tandem mass spectrometry for determination of impurities in the anti-cancer drug isophosphoramide mustard
Richard B. Cole, Chau-Wen Chou, Stephen M. Boué et al. · International Journal of Mass Spectrometry
|
16 Jan 2004 |
1 |
| 20 |
Comparative Preclinical Pharmacology and Toxicology for 4-demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOCPEN) — A Potential Neuro-Alkylating Agent for Glioblastoma (GBM) and Metastatic Cancers Involving the Central Nervous System
Lee Roy Morgan, Andrew H. Rodgers, Gérard Bastian et al. · InTech eBooks
Book chapterOpen access |
11 Jun 2014 |
1 |
| 21 |
Preclinical Activity of 4-Demethyl-4-cholesteryloxycarbonylpenclomedine in Melanoma
Philip Adam Friedlander, Lee Roy Morgan, EDMUND N. BENES et al. · Anticancer Research
Open access |
27 Mar 2023 |
0 |
| 22 |
New Approaches in the Treatment of Glioblastoma Multiforme
Lee Roy Morgan, Branko S. Jursic, Marcus L. Ware et al. · IntechOpen eBooks
Book chapterOpen access |
12 Aug 2022 |
0 |
| 23 |
Phase I Clinical Trial: Results From The Use Of 4-Demethyl-4-Cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) Plus Radiation As Treatment For Cancers Involving The CNS
Steven Joseph DiBiase, Roy S. Weiner, T Mahmood et al. · International Journal of Radiation Oncology*Biology*Physics
|
23 Oct 2020 |
0 |
| 24 |
ChemInform Abstract: Anticancer Properties for 4,4′‐Dihydroxybenzophenone‐2,4‐dinitrophenylhydrazone (A‐007)/3,7‐Diaminophenothiazin‐5‐ium Double Salts.
Lee Roy Morgan, Andrew H. Rodgers, Blaise W. LeBlanc et al. · ChemInform
|
6 Nov 2001 |
0 |
| 25 |
ChemInform Abstract: N‐Alkylation of Aromatic and Heteroaromatic 2,4‐ Dinitrophenylhydrazones with Potassium Fluoride on Alumina.
Kannappan Thangaraj, Lee Roy Morgan · ChemInform
|
17 Jan 1995 |
0 |
| 26 |
A Nutrition Perspective on the Ketogenic Diet as Therapy for Malignant Brain Cancer
Meredith Ann Morgan · IntechOpen eBooks
Book chapterOpen access |
13 Feb 2019 |
0 |
| 27 |
Comparative Anticancer Activity in Human Tumor Xenograft Models, Preclinical Pharmacology and Toxicology for 4- Hydroperoxyifosfamide (HOOI): A Potential Neuro-Alkylating Agent for Primary and Metastatic Cancers Involving the Central Nervous System
Lee Roy Morgan, Andrew H. Rodgers, Gérard Bastian et al. · InTech eBooks
Book chapterOpen access |
23 Mar 2017 |
0 |
| 28 |
Relative bioavailability of 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007) in rats and monkeys.
S Subramasnian, Andrew H. Rodgers, Lee Roy Morgan et al. · PubMed
|
1996 |
0 |
| 29 |
ATCT-14CHEMOSENSITIVITY OF PRIMARY AND METASTATIC CNS TUMORS TO 4-DEMETHYL-4-CHOLESTERYLOXYCARBONYLPENCLOMEDINE (DM-CHOC-PEN) AND TEMOZOLOMIDE
Juan Carlos Vera, Michael D. Strong, Mansour Mathkour et al. · Neuro-Oncology
Open access |
Nov 2015 |
0 |
| 30 |
Toxicology off 4,4'-dihydroxyben20phenone-2,4-dinitrophyenylhydrazone (A-007)
Lee Roy Morgan, Michael C. Hooper, Caroline Hooper et al. · European Journal of Pharmacology
|
Jul 1990 |
0 |
| 31 |
Isophosphoramide mustard-lysine (IPM-L; ZIO-201): A new alkylator for bone marrow transplants
Lee Roy Morgan, Robert F. Struck, Andrew Rodgers et al. · Transplantation and Cellular Therapy
Open access |
Feb 2006 |
0 |
| 32 |
Chemotherapy associated memory/learning loss and reversal with supplemental amino acids in a rat model
Lee Roy Morgan, Melissa E. Thornton, Edmund N. Benes et al. · The FASEB Journal
|
Apr 2009 |
0 |